CHA2DS2‐VASc Score as a Predictor for Atrial Fibrillation Recurrence and Clinical Outcomes Following Pulmonary Vein Isolation

ABSTRACT Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation (PVI) is an established rhythm‐control strategy for...

Full description

Saved in:
Bibliographic Details
Published inAnnals of noninvasive electrocardiology Vol. 30; no. 3; pp. e70088 - n/a
Main Authors Gabarin, Mustafa, Suleiman, Mahmoud, Elias, Adi, Marai, Ibrahim, Beinart, Roy, Nof, Eyal, Michowitz, Yoav, Glikson, Michael, Konstantino, Yuval, Haim, Moti, Luria, David, Pereg, David, Laish‐Farkash, Avishag, Omelchenko, Alexander
Format Journal Article
LanguageEnglish
Published Hoboken John Wiley and Sons Inc 01.05.2025
Wiley
Subjects
Online AccessGet full text
ISSN1082-720X
1542-474X
1542-474X
DOI10.1111/anec.70088

Cover

Abstract ABSTRACT Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation (PVI) is an established rhythm‐control strategy for AF. Although the CHA2DS2‐VASc score is primarily used to estimate stroke risk in patients with AF, its potential utility in predicting AF recurrence after PVI has not been fully explored in contemporary, real‐world multicenter settings. Aim To evaluate the association between the CHA2DS2‐VASc score and both AF recurrence and adverse clinical outcomes following PVI. Methods We conducted a retrospective cohort study using the Israeli Catheter Ablation Registry (ICAR), including 860 patients undergoing their first PVI for AF. Patients were grouped by CHA2DS2‐VASc score (0–1, 2–4, > 5). The primary endpoint was AF recurrence within 12 months. Secondary endpoints included re‐hospitalization, major adverse cardiovascular events (MACE), and all‐cause mortality. Results AF recurrence occurred in 32% of patients. Recurrence rates were 25.7%, 31.4%, and 51% across the low, intermediate, and high CHA2DS2‐VASc score groups, respectively. A higher score was independently associated with increased recurrence risk (HR = 2.88; 95% CI, 1.75–4.74; p < 0.001). Elevated CHA2DS2‐VASc scores also correlated with higher MACE and re‐hospitalization rates. No significant difference in all‐cause mortality was observed. Conclusion The CHA2DS2‐VASc score is an independent predictor of AF recurrence and adverse outcomes after PVI. Its simplicity, availability, and routine use make it a clinically useful tool to support preprocedural risk stratification in AF patients undergoing ablation. The CHA2DS2‐VASc score independently predicts atrial fibrillation recurrence and adverse outcomes after pulmonary vein isolation. Its routine clinical use offers a simple tool to support risk stratification and personalized post‐ablation care.
AbstractList ABSTRACT Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation (PVI) is an established rhythm‐control strategy for AF. Although the CHA2DS2‐VASc score is primarily used to estimate stroke risk in patients with AF, its potential utility in predicting AF recurrence after PVI has not been fully explored in contemporary, real‐world multicenter settings. Aim To evaluate the association between the CHA2DS2‐VASc score and both AF recurrence and adverse clinical outcomes following PVI. Methods We conducted a retrospective cohort study using the Israeli Catheter Ablation Registry (ICAR), including 860 patients undergoing their first PVI for AF. Patients were grouped by CHA2DS2‐VASc score (0–1, 2–4, > 5). The primary endpoint was AF recurrence within 12 months. Secondary endpoints included re‐hospitalization, major adverse cardiovascular events (MACE), and all‐cause mortality. Results AF recurrence occurred in 32% of patients. Recurrence rates were 25.7%, 31.4%, and 51% across the low, intermediate, and high CHA2DS2‐VASc score groups, respectively. A higher score was independently associated with increased recurrence risk (HR = 2.88; 95% CI, 1.75–4.74; p < 0.001). Elevated CHA2DS2‐VASc scores also correlated with higher MACE and re‐hospitalization rates. No significant difference in all‐cause mortality was observed. Conclusion The CHA2DS2‐VASc score is an independent predictor of AF recurrence and adverse outcomes after PVI. Its simplicity, availability, and routine use make it a clinically useful tool to support preprocedural risk stratification in AF patients undergoing ablation.
The CHA 2 DS 2 ‐VASc score independently predicts atrial fibrillation recurrence and adverse outcomes after pulmonary vein isolation. Its routine clinical use offers a simple tool to support risk stratification and personalized post‐ablation care.
ABSTRACT Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation (PVI) is an established rhythm‐control strategy for AF. Although the CHA2DS2‐VASc score is primarily used to estimate stroke risk in patients with AF, its potential utility in predicting AF recurrence after PVI has not been fully explored in contemporary, real‐world multicenter settings. Aim To evaluate the association between the CHA2DS2‐VASc score and both AF recurrence and adverse clinical outcomes following PVI. Methods We conducted a retrospective cohort study using the Israeli Catheter Ablation Registry (ICAR), including 860 patients undergoing their first PVI for AF. Patients were grouped by CHA2DS2‐VASc score (0–1, 2–4, > 5). The primary endpoint was AF recurrence within 12 months. Secondary endpoints included re‐hospitalization, major adverse cardiovascular events (MACE), and all‐cause mortality. Results AF recurrence occurred in 32% of patients. Recurrence rates were 25.7%, 31.4%, and 51% across the low, intermediate, and high CHA2DS2‐VASc score groups, respectively. A higher score was independently associated with increased recurrence risk (HR = 2.88; 95% CI, 1.75–4.74; p < 0.001). Elevated CHA2DS2‐VASc scores also correlated with higher MACE and re‐hospitalization rates. No significant difference in all‐cause mortality was observed. Conclusion The CHA2DS2‐VASc score is an independent predictor of AF recurrence and adverse outcomes after PVI. Its simplicity, availability, and routine use make it a clinically useful tool to support preprocedural risk stratification in AF patients undergoing ablation. The CHA2DS2‐VASc score independently predicts atrial fibrillation recurrence and adverse outcomes after pulmonary vein isolation. Its routine clinical use offers a simple tool to support risk stratification and personalized post‐ablation care.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation (PVI) is an established rhythm-control strategy for AF. Although the CHA2DS2-VASc score is primarily used to estimate stroke risk in patients with AF, its potential utility in predicting AF recurrence after PVI has not been fully explored in contemporary, real-world multicenter settings.BACKGROUNDAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation (PVI) is an established rhythm-control strategy for AF. Although the CHA2DS2-VASc score is primarily used to estimate stroke risk in patients with AF, its potential utility in predicting AF recurrence after PVI has not been fully explored in contemporary, real-world multicenter settings.To evaluate the association between the CHA2DS2-VASc score and both AF recurrence and adverse clinical outcomes following PVI.AIMTo evaluate the association between the CHA2DS2-VASc score and both AF recurrence and adverse clinical outcomes following PVI.We conducted a retrospective cohort study using the Israeli Catheter Ablation Registry (ICAR), including 860 patients undergoing their first PVI for AF. Patients were grouped by CHA2DS2-VASc score (0-1, 2-4, > 5). The primary endpoint was AF recurrence within 12 months. Secondary endpoints included re-hospitalization, major adverse cardiovascular events (MACE), and all-cause mortality.METHODSWe conducted a retrospective cohort study using the Israeli Catheter Ablation Registry (ICAR), including 860 patients undergoing their first PVI for AF. Patients were grouped by CHA2DS2-VASc score (0-1, 2-4, > 5). The primary endpoint was AF recurrence within 12 months. Secondary endpoints included re-hospitalization, major adverse cardiovascular events (MACE), and all-cause mortality.AF recurrence occurred in 32% of patients. Recurrence rates were 25.7%, 31.4%, and 51% across the low, intermediate, and high CHA2DS2-VASc score groups, respectively. A higher score was independently associated with increased recurrence risk (HR = 2.88; 95% CI, 1.75-4.74; p < 0.001). Elevated CHA2DS2-VASc scores also correlated with higher MACE and re-hospitalization rates. No significant difference in all-cause mortality was observed.RESULTSAF recurrence occurred in 32% of patients. Recurrence rates were 25.7%, 31.4%, and 51% across the low, intermediate, and high CHA2DS2-VASc score groups, respectively. A higher score was independently associated with increased recurrence risk (HR = 2.88; 95% CI, 1.75-4.74; p < 0.001). Elevated CHA2DS2-VASc scores also correlated with higher MACE and re-hospitalization rates. No significant difference in all-cause mortality was observed.The CHA2DS2-VASc score is an independent predictor of AF recurrence and adverse outcomes after PVI. Its simplicity, availability, and routine use make it a clinically useful tool to support preprocedural risk stratification in AF patients undergoing ablation.CONCLUSIONThe CHA2DS2-VASc score is an independent predictor of AF recurrence and adverse outcomes after PVI. Its simplicity, availability, and routine use make it a clinically useful tool to support preprocedural risk stratification in AF patients undergoing ablation.
Author Suleiman, Mahmoud
Elias, Adi
Pereg, David
Omelchenko, Alexander
Nof, Eyal
Michowitz, Yoav
Luria, David
Konstantino, Yuval
Marai, Ibrahim
Gabarin, Mustafa
Glikson, Michael
Beinart, Roy
Laish‐Farkash, Avishag
Haim, Moti
AuthorAffiliation 9 Department of Cardiology, Electrophysiology and Pacing Unit Assuta Ashdod University Medical Center, ben‐Gurion University of the Negev Ashdod Israel
7 Department of Cardiology, Cardiac Electrophysiology and Pacing Soroka University Hospital, ben‐Gurion University of the Negev Beer‐Sheva Israel
5 Heart Institute, Sheba Medical Center, Tel‐Hashomer, Israel and Sackler School of Medicine Tel Aviv Israel
3 Rappaport Faculty of Medicine Technion‐Israel Institute of Technology Haifa Israel
6 Jesselson Integrated Heart Center Shaare Zedek Medical Center and Hebrew University Jerusalem Israel
1 Cardiology Department, Meir Medical Center, Kfar‐Saba and Sackler Faculty of Medicine Tel‐Aviv University Tel Aviv Israel
8 Department of Cardiology, Hadassah Medical Organization and Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
4 Cardiology Department, Baruch Padeh Medical Center, the Azrieli Faculty of Medicine in the Galilee Bar‐Ilan University Safed Israel
2 Eyal Ofer Heart Hospita
AuthorAffiliation_xml – name: 2 Eyal Ofer Heart Hospital, Cardiac Electrophysiology and Pacing Rambam Health Care Campus Haifa Israel
– name: 1 Cardiology Department, Meir Medical Center, Kfar‐Saba and Sackler Faculty of Medicine Tel‐Aviv University Tel Aviv Israel
– name: 7 Department of Cardiology, Cardiac Electrophysiology and Pacing Soroka University Hospital, ben‐Gurion University of the Negev Beer‐Sheva Israel
– name: 9 Department of Cardiology, Electrophysiology and Pacing Unit Assuta Ashdod University Medical Center, ben‐Gurion University of the Negev Ashdod Israel
– name: 5 Heart Institute, Sheba Medical Center, Tel‐Hashomer, Israel and Sackler School of Medicine Tel Aviv Israel
– name: 6 Jesselson Integrated Heart Center Shaare Zedek Medical Center and Hebrew University Jerusalem Israel
– name: 3 Rappaport Faculty of Medicine Technion‐Israel Institute of Technology Haifa Israel
– name: 4 Cardiology Department, Baruch Padeh Medical Center, the Azrieli Faculty of Medicine in the Galilee Bar‐Ilan University Safed Israel
– name: 8 Department of Cardiology, Hadassah Medical Organization and Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel
Author_xml – sequence: 1
  givenname: Mustafa
  orcidid: 0000-0003-4081-2727
  surname: Gabarin
  fullname: Gabarin, Mustafa
  email: mustafa.gabarin88@gmail.com
  organization: Tel‐Aviv University
– sequence: 2
  givenname: Mahmoud
  surname: Suleiman
  fullname: Suleiman, Mahmoud
  organization: Technion‐Israel Institute of Technology
– sequence: 3
  givenname: Adi
  surname: Elias
  fullname: Elias, Adi
  organization: Rambam Health Care Campus
– sequence: 4
  givenname: Ibrahim
  surname: Marai
  fullname: Marai, Ibrahim
  organization: Bar‐Ilan University
– sequence: 5
  givenname: Roy
  surname: Beinart
  fullname: Beinart, Roy
  organization: Heart Institute, Sheba Medical Center, Tel‐Hashomer, Israel and Sackler School of Medicine
– sequence: 6
  givenname: Eyal
  surname: Nof
  fullname: Nof, Eyal
  organization: Heart Institute, Sheba Medical Center, Tel‐Hashomer, Israel and Sackler School of Medicine
– sequence: 7
  givenname: Yoav
  surname: Michowitz
  fullname: Michowitz, Yoav
  organization: Shaare Zedek Medical Center and Hebrew University
– sequence: 8
  givenname: Michael
  surname: Glikson
  fullname: Glikson, Michael
  organization: Shaare Zedek Medical Center and Hebrew University
– sequence: 9
  givenname: Yuval
  surname: Konstantino
  fullname: Konstantino, Yuval
  organization: Soroka University Hospital, ben‐Gurion University of the Negev
– sequence: 10
  givenname: Moti
  surname: Haim
  fullname: Haim, Moti
  organization: Soroka University Hospital, ben‐Gurion University of the Negev
– sequence: 11
  givenname: David
  surname: Luria
  fullname: Luria, David
  organization: Hebrew University of Jerusalem
– sequence: 12
  givenname: David
  surname: Pereg
  fullname: Pereg, David
  organization: Tel‐Aviv University
– sequence: 13
  givenname: Avishag
  surname: Laish‐Farkash
  fullname: Laish‐Farkash, Avishag
  organization: Assuta Ashdod University Medical Center, ben‐Gurion University of the Negev
– sequence: 14
  givenname: Alexander
  surname: Omelchenko
  fullname: Omelchenko, Alexander
  organization: Tel‐Aviv University
BookMark eNpVkc1u1DAQxy1UJNrChSfwkUuK7XzYOaEodOlKFa1YqHqz_DFZXDl2cRKqnuAReEaeBO9uhdSRRjMa__3zyP8TdBRiAITeUnJGc7xXAcwZJ0SIF-iY1hUrKl7dHuWeCFZwRm5foZNpuiOEsYrxY_Srv-jYxw37-_vPTbcxeGNiAqwmrPB1AuvMHBMecnZzcsrjldPJea9mFwP-AmZJCYLJN4LFvXfBmSy6WmYTR5jwKnofH1zY4uvFjzGo9IhvwAW8nuKB8Rq9HJSf4M1TPUXfVudf-4vi8urTuu8uC1u2RBS64lozVnJqDLcKNBcNaNUyq0o6cMKFYgOprK6buiKqJErUoq2zbgAjBihP0frAtVHdyfvkxryLjMrJ_SCmrVRpdsaDhKZtdQs1pZpVdWO0zalpA8xYGITJrA8H1v2iR7AGwpyUfwZ9fhLcd7mNPyVlpCGU8Ux490RI8ccC0yxHNxnI_xogLpMsGWFlK3i7k9KD9MF5ePz_CCVyZ7jcGS73hsvu83m_78p_8hWmTQ
ContentType Journal Article
Copyright 2025 The Author(s). published by Wiley Periodicals LLC.
2025 The Author(s). Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
Copyright_xml – notice: 2025 The Author(s). published by Wiley Periodicals LLC.
– notice: 2025 The Author(s). Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
DBID 24P
7X8
5PM
DOA
DOI 10.1111/anec.70088
DatabaseName Wiley Online Library Open Access
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1542-474X
EndPage n/a
ExternalDocumentID oai_doaj_org_article_e699b9e511b2456cbd6cbb16e2cdef8c
PMC12060127
ANEC70088
Genre researchArticle
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
31~
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANHP
AAONW
AAWTL
AAZKR
ABCQN
ABCUV
ABEML
ABPVW
ABUWG
ACBWZ
ACCFJ
ACCMX
ACGFS
ACMXC
ACPOU
ACRPL
ACSCC
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADMGS
ADNMO
ADPDF
ADXAS
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AFBPY
AFEBI
AFGKR
AFKRA
AFPKN
AFZJQ
AGQPQ
AHEFC
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BBNVY
BDRZF
BENPR
BFHJK
BHBCM
BHPHI
BMXJE
BPMNR
BROTX
BRXPI
BY8
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
EBS
EJD
EMB
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FYUFA
FZ0
G-S
G.N
GODZA
GROUPED_DOAJ
H.X
HCIFZ
HF~
HMCUK
HVGLF
HZI
HZ~
IAO
IHE
IHR
INH
J0M
K48
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M7P
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PHGZM
PHGZT
PIMPY
PMFND
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RPM
RX1
SAMSI
SUPJJ
SV3
TEORI
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
ZZTAW
~IA
~WT
7X8
AAFWJ
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
PQGLB
PUEGO
WIN
5PM
ID FETCH-LOGICAL-d3908-b47bb22371cc7daeb786eba92da31f7078a2f04db56540a30a85895eb7fec8fe3
IEDL.DBID DR2
ISSN 1082-720X
1542-474X
IngestDate Wed Aug 27 01:22:31 EDT 2025
Thu Aug 21 18:27:14 EDT 2025
Fri Sep 05 17:11:39 EDT 2025
Tue May 27 09:41:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Attribution
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-d3908-b47bb22371cc7daeb786eba92da31f7078a2f04db56540a30a85895eb7fec8fe3
Notes Mustafa Gabarin, Mahmoud Suleiman, Adi Elias, Ibrahim Marai, Roy Beinart, Eyal Nof, Yoav Michowitz, Michael Glikson, Yuval Konstantino, Moti Haim, David Luria, David Pereg, Avishag Laish‐Farkash, and Alexander Omelchenko takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4081-2727
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fanec.70088
PQID 3202398797
PQPubID 23479
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_e699b9e511b2456cbd6cbb16e2cdef8c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12060127
proquest_miscellaneous_3202398797
wiley_primary_10_1111_anec_70088_ANEC70088
PublicationCentury 2000
PublicationDate May 2025
PublicationDateYYYYMMDD 2025-05-01
PublicationDate_xml – month: 05
  year: 2025
  text: May 2025
PublicationDecade 2020
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
PublicationTitle Annals of noninvasive electrocardiology
PublicationYear 2025
Publisher John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley and Sons Inc
– name: Wiley
References 2007; 28
2015; 12
2021; 42
2003; 107
2023; 66
2022; 180
2015; 104
2006; 27
2013; 61
2017; 24
2013; 167
2014; 16
2020; 27
2008; 5
2019; 139
2024; 67
2014; 7
2014; 383
2018; 20
2003; 86
References_xml – volume: 12
  start-page: 681
  issue: 4
  year: 2015
  end-page: 686
  article-title: The Impact of Risk Score (CHADS2 Versus CHA2DS2‐VASc) on Long‐Term Outcomes After Atrial Fibrillation Ablation
  publication-title: Heart Rhythm
– volume: 104
  start-page: 871
  issue: 10
  year: 2015
  end-page: 876
  article-title: The APPLE Score: A Novel and Simple Score for the Prediction of Rhythm Outcomes After Catheter Ablation of Atrial Fibrillation
  publication-title: Clinical Research in Cardiology
– volume: 27
  start-page: 216
  issue: 2
  year: 2006
  end-page: 221
  article-title: Catheter Ablation Treatment in Patients With Drug‐Refractory Atrial Fibrillation: A Prospective, Multi‐Centre, Randomized, Controlled Study (Catheter Ablation for the Cure of Atrial Fibrillation Study)
  publication-title: European Heart Journal
– volume: 67
  start-page: 921
  issue: 5
  year: 2024
  end-page: 1072
  article-title: European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
  publication-title: Journal of Interventional Cardiac Electrophysiology
– volume: 61
  start-page: 1713
  issue: 16
  year: 2013
  end-page: 1723
  article-title: Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation: First Results of the North American Arctic Front (STOP AF) Pivotal Trial
  publication-title: Journal of the American College of Cardiology
– volume: 24
  start-page: 1555
  issue: 14
  year: 2017
  end-page: 1566
  article-title: Atrial Fibrillation and the Risk for Myocardial Infarction, All‐Cause Mortality and Heart Failure: A Systematic Review and Meta‐Analysis
  publication-title: European Journal of Preventive Cardiology
– volume: 5
  start-page: 679
  issue: 5
  year: 2008
  end-page: 685
  article-title: Clinical Predictors and Relationship Between Early and Late Atrial Tachyarrhythmias After Pulmonary Vein Antrum Isolation
  publication-title: Heart Rhythm
– volume: 42
  start-page: 373
  issue: 5
  year: 2021
  end-page: 498
  article-title: ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio‐Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC
  publication-title: European Heart Journal
– volume: 139
  start-page: e56
  issue: 10
  year: 2019
  end-page: e528
  article-title: American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
  publication-title: Heart Disease and Stroke Statistics‐2019 Update: A Report From the American Heart Association. Circulation
– volume: 167
  start-page: 1984
  issue: 5
  year: 2013
  end-page: 1989
  article-title: Which Are the Most Reliable Predictors of Recurrence of Atrial Fibrillation After Transcatheter Ablation?: A Meta‐Analysis
  publication-title: International Journal of Cardiology
– volume: 7
  start-page: 281
  issue: 2
  year: 2014
  end-page: 287
  article-title: Comparison of CHADS2, R2CHADS2, and CHA2DS2‐VASc Scores for the Prediction of Rhythm Outcomes After Catheter Ablation of Atrial Fibrillation: The Leipzig Heart Center AF Ablation Registry
  publication-title: Circulation. Arrhythmia and Electrophysiology
– volume: 66
  start-page: 1193
  issue: 5
  year: 2023
  end-page: 1200
  article-title: Role of CHA DS ‐VASc Score in Predicting Atrial Fibrillation Recurrence in Patients Undergoing Pulmonary Vein Isolation With Cryoballoon Ablation
  publication-title: Journal of Interventional Cardiac Electrophysiology
– volume: 180
  start-page: 24
  issue: 1
  year: 2022
  end-page: 28
  article-title: CHA DS ‐VASc Score, Mortality and Acute Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation
  publication-title: American Journal of Cardiology
– volume: 16
  start-page: 202
  issue: 2
  year: 2014
  end-page: 207
  article-title: CHADS2 and CHA2DS2‐VASc Scores as Predictors of Left Atrial Ablation Outcomes for Paroxysmal Atrial Fibrillation
  publication-title: Europace
– volume: 383
  start-page: 955
  issue: 9921
  year: 2014
  end-page: 962
  article-title: Comparison of the Efficacy and Safety of New Oral Anticoagulants With Warfarin in Patients With Atrial Fibrillation: A Meta‐Analysis of Randomised Trials
  publication-title: Lancet
– volume: 28
  start-page: 836
  issue: 7
  year: 2007
  end-page: 841
  article-title: Pre‐Procedural Predictors of Atrial Fibrillation Recurrence After Circumferential Pulmonary Vein Ablation
  publication-title: European Heart Journal
– volume: 20
  start-page: f460
  year: 2018
  end-page: f462
  article-title: Development and Validation of a Risk Score for Predicting Atrial Fibrillation Recurrence After a First Catheter Ablation Procedure: ATLAS Score‐Author's Reply
  publication-title: Europace
– volume: 107
  start-page: 2920
  issue: 23
  year: 2003
  end-page: 2925
  article-title: Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study
  publication-title: Circulation
– volume: 27
  start-page: 633
  issue: 6
  year: 2020
  end-page: 644
  article-title: Association Between Clinical Risk Scores and Mortality in Atrial Fibrillation: Systematic Review and Network Meta‐Regression of 669,000 Patients
  publication-title: European Journal of Preventive Cardiology
– volume: 86
  start-page: S8
  issue: Suppl 1
  year: 2003
  end-page: S16
  article-title: A Randomized Clinical Trial of the Efficacy of Radiofrequency Catheter Ablation and Amiodarone in the Treatment of Symptomatic Atrial Fibrillation
  publication-title: Journal of the Medical Association of Thailand
SSID ssj0022427
Score 2.3787978
Snippet ABSTRACT Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications...
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications such as ischemic...
The CHA 2 DS 2 ‐VASc score independently predicts atrial fibrillation recurrence and adverse outcomes after pulmonary vein isolation. Its routine clinical use...
ABSTRACT Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications...
SourceID doaj
pubmedcentral
proquest
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Publisher
StartPage e70088
SubjectTerms AF recurrence
atrial fibrillation (AF)
CHA2DS2‐VASc score
Original
pulmonary vein isolation (PVI)
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLggJiKVSuxAkp4DhObB_D0tWC1FKxtNpbNH5EVFpl0T6EOMFP4DfyS5hxslWXCxcOkaLEzsPzKf4mM_6GsZd5MOCDUlmlLGQqooNirGyzggCgTVmFktYOn51X00v1YV7Ob5X6opywXh64H7g3sbLW2Yi8wFGMzruAm8urKH2IrfH09RVW7JypwdXCiUf3qfXIH6WYD8KklMMDXfSvNU59ZpDp3-OWf2dG3masacqZPGD3B67I6_4ZH7I7sTtkd8-GaPgj9mM8reW7mfz989dVPfN8RpKUHNYc-MWKWqE_zZGU8jrV5uATSu9f9Mlv_BP9aE9L_Th0gQ_6oAv-cbtBEMY1nyBClt9wZuMX2wWCFVbf-VW87vh7hGu6xmN2OTn9PJ5mQ0GFLBRWmMwp7RzyAZ17rwNEp00VHVgZoMhb0v0B2QoVHLI8JaAQYEpjS2zXRm_aWDxhB92yi08ZlyI6V2pBUVO8qgIAm8cA4FtkBM6P2Fsa2-Zrr5nRkIp1OoC2bQbbNv-y7Yid7CzTIOoplIHWW27XTar6bo22esTMnsn27rh_prv-kvSzc0kiNBK7vkrWvemyc4gIIk2CSFOfn47T3rP_8UJH7J6k-sEpYfI5O9istvEFkpqNO074_QOmRfj_
  priority: 102
  providerName: Directory of Open Access Journals
Title CHA2DS2‐VASc Score as a Predictor for Atrial Fibrillation Recurrence and Clinical Outcomes Following Pulmonary Vein Isolation
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fanec.70088
https://www.proquest.com/docview/3202398797
https://pubmed.ncbi.nlm.nih.gov/PMC12060127
https://doaj.org/article/e699b9e511b2456cbd6cbb16e2cdef8c
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBbbLZRetm-6fQQVeio42LJsSdCLN5uQFjYNSXfJpRi93C4NzpIHhV7an9Df2F_SGdlJN3trDzbGlmSZ0Xg-STPfEPI6cVJbx3mUc6Uj7mGCIhWrohQHgJBZ7jKMHT4b5cNz_n6WzQ7I220sTMMPsVtwQ80I_2tUcG1W15Rc1952BZgwjPRN0hyJ808nO-4oME0hX2sSI4Rk8azlJkU3nr9VW6b-PXh50znyOmgNVmdwj3za9rdxNvna3axN136_QeX4vx90nxy1cJQWzfh5QA58_ZDcOWs33B-RH71hwU6n7PfPXxfF1NIpsl5SvaKajpdYCqbsFHAvLUL6DzrACIJ5419HJ7iWH6IJqa4dbSlI5_TDZg198ys6gEG4-AbGk443c9AH6Du98Jc1fQcaEdp4TM4H_Y-9YdTmbIhcqmIZGS6MAcghEmuF094ImXujFXM6TSqkFtKsirkzACR5rNNYy0yqDMpV3srKp0_IYb2o_VNCWeyNyUSMG7PQKtdaq8Q7rW0FoMPYY3KCsiuvGlqOEomyw43F8nPZ6l3pc6WM8gArDW7xWuPgMEnumXW-ktDIq63kS1As3C0BOSw2qzIklldSKHFM5N6Q2Hvj_pP68kug6E4Y8twwqPomiHxXZTvnQmGXQdhlMer3wtWzfyn8nNxlmIo4-F6-IIfr5ca_BHy0Nh1yi_ExnMVMdMjtk_5oPOmEtYZO0JA_SPQUog
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSMClanmI8miNxAkpKHGc2D6GpavtY5cV21Z7s_wKVFpl0T7EsfwEfiO_hBknXbrcOESKEtuRPDPxN57xN4S8y7w0znOelFyZhAdwUKRidZKjAghZlL7As8PDUTm45KfTYtrl5uBZmJYfYrPhhpYR_9do4LghfcfKTRPcBwFrmLxPHvASfBckdubjjb8Fq49o8-sBRLJ02rGTYiLP374dV_8WwPw3PfIubI3rTn-P7HaAkVathPfJvdA8IQ-HXUj8KbnpDSr2acJ-__x1VU0cnSAvJTVLauh4ga3AqaaATGkVC3TQPub4z9oMOPoFd9vjeT9qGk87ktAZ_bxewXSEJe2Dmsx_wPJGx-sZaCxMF70K1w09AZ2NYzwjl_3ji94g6aoqJD5XqUwsF9YCKBCZc8KbYIUsgzWKeZNnNZL_GFan3FuAejw1eWpkIVUB7ergZB3y52SnmTfhBaEsDdYWIsXQKYzKjTEqC94YVwMssO6AfMS51d9b4gyNVNbxwXzxVXeWoUOplFUBgJ_FIKyzHi6blYE5H2oJg7y9lYwG1cd4Bkhvvl7qWPpdSaHEAZFbItv64vab5vpbJNHOGDLRMOj6Pkp30-XWK0IV0VFFdDU67sW7l__T-Ig8GlwMz_X5yejsFXnMsHBwzJR8TXZWi3V4A2hmZQ-jzv4BlzDzRw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3LbtQwFLVKkSo2iKcoFDASK6SgxHFiW-omTBtNgQ4jhlazs_wKVBplqnmIJXwC38iXcK-TGTrsWESKEtuRfM_NPbavjwl5nXlpnOc8KbkyCQ8wQJGKNUmOABCyKH2Be4fPR-Xwgr-fFtM9crzZC9PpQ2wn3NAz4v8aHfzaNzec3LTBvRUQwuQtcpsD8BDfjI-3wy0IPqJLrwcOydJpL06KeTx_6_ZS_Tv88t_syJusNYad-h652_NFWnUGvk_2QvuAHJz3K-IPyY_BsGInE_b756_LauLoBGUpqVlSQ8cLLAVjagrElFbxfA5aY4r_rEuAo59xsj1u96Om9bTXCJ3RT-sV9EZY0hpQMv8O0Y2O1zMALPQWvQxXLT0DyMY2HpGL-vTLYJj0hyokPlepTCwX1gInEJlzwptgoeOCNYp5k2cNav8Y1qTcW2B6PDV5amQhVQHlmuBkE_LHZL-dt-EJoSwN1hYixZVTaJUbY1QWvDGuAVZg3SF5h32rrzvdDI1K1vHBfPFV946hQ6mUVQF4n8U1WGc9XDYrA3M-NBIaebWxjAbk43IGWG--Xup48ruSQolDIndMtvPF3Tft1beooZ0xFKJhUPVNtO62ymZQhBDRESK6Gp0O4t3T_yn8khyMT2r98Wz04Rm5w_DY4JgneUT2V4t1eA5cZmVfRMj-AVbm8oI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CHA2DS2%E2%80%90VASc+Score+as+a+Predictor+for+Atrial+Fibrillation+Recurrence+and+Clinical+Outcomes+Following+Pulmonary+Vein+Isolation&rft.jtitle=Annals+of+noninvasive+electrocardiology&rft.au=Gabarin%2C+Mustafa&rft.au=Suleiman%2C+Mahmoud&rft.au=Elias%2C+Adi&rft.au=Marai%2C+Ibrahim&rft.date=2025-05-01&rft.issn=1082-720X&rft.eissn=1542-474X&rft.volume=30&rft.issue=3&rft.epage=n%2Fa&rft_id=info:doi/10.1111%2Fanec.70088&rft.externalDBID=10.1111%252Fanec.70088&rft.externalDocID=ANEC70088
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1082-720X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1082-720X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1082-720X&client=summon